MedPath

Feasibility and efficacy of a guided self-help intervention in supporting mental health professionals in making decisions about disclosure of their own mental health challenges

Not Applicable
Completed
Conditions
Mental health
Mental and Behavioural Disorders
Registration Number
ISRCTN18418155
Lead Sponsor
niversity College London
Brief Summary

2021 Results article in https://discovery.ucl.ac.uk/id/eprint/10135432/ (added 07/10/2021)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
61
Inclusion Criteria

1. UK based mental health professional, whether qualified or currently in training, and not yet fully retired.
2. Participants must self-define as currently experiencing psychological, emotional and/or behavioural difficulties that have diminished their capacity for coping with the ordinary demands of life, or as having experienced such difficulties in the past.
3. They must have either not disclosed their experiences of mental health problems, or only in some settings.
4. Not at acute risk, defined as not having experienced thoughts that they would be better off dead or of hurting self in some way nearly every day.

Exclusion Criteria

1. Potential participants who are publicly ‘out’ about their current or past difficulties will not be eligible for the study.
2. Participants must be willing to complete the battery of standardised measures in order to take part in the research study, although they may leave individual items unanswered.
3. No personal experience of mental health problems
4. Fully retired from their post as a mental health service provider

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> 1.Stigma stress is measured using the Stigma Stress Scale (Rüsch et al, 2009), which measures the primary appraisal of stigma as harmful and the secondary appraisal of personal resources to cope with stigma.<br><br> Outcomes will be measured at 3 time points in both the intervention and control group: baseline (T0), 4 to 6 weeks from baseline (T1), and 10 to 12 weeks from baseline (T2). Participants in the intervention arm complete the T1 measure after they have completed the 3 core HOP-MHP sessions, and the T2 measures after they have completed the booster session. Those who complete the core and booster sessions at a slower pace than intended will complete the outcome measures over a somewhat longer timeframe, of T1 up to 8 weeks from baseline and T2 up to 16 weeks from baseline.<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath